Endorse Company

The ISF primarily addresses the following key issues:

  • Early diagnosis and identification of patients at risk
  • Best use of current management strategies
  • Integration of monoclonal antibodies and other emerging new adjunctive therapies into current treatment strategies
  • Ethical and economic issues that influence management decision-making
  • Standardization of training provided to intensive care providers replace with your keywords

Products